INSURANCE – Adds to existing law to establish provisions regarding coverage of anticancer medications under health benefit plans.

This Idaho bill (H 530) requires health insurance plans to cover anticancer medications with equal cost-sharing for oral and injected treatments. Specifically, it mandates that out-of-pocket costs for oral anticancer drugs cannot exceed $250 per 30-day supply, matching the cost limits for injected options. The law clarifies that plans aren’t required to classify anticancer medications as "medical benefits" but prohibits them from increasing costs or reclassifying coverage to avoid compliance. It takes effect July 1, 2026, directly affecting insurers and patients using oral anticancer medications under Idaho health plans.